Advertisement
Advertisement
IQV
IQVIA Holdings Inc.
228.20
USDSponsored
-5.16
-2.21%
Aug 04, 15:59 UTC -4
Closed
After-Market
227.71
-0.49
-0.22%
IQV Earnings Reports
Positive Surprise Ratio
IQV beat 37 of 42 last estimates.
88%
Next Report
Date of Next Report
Oct 26, 2026
Estimate for Q3 26 (Revenue/ EPS)
$4.40B
/$3.29
Implied change from Q2 26 (Revenue/ EPS)
+0.66%
/+4.44%
Implied change from Q3 25 (Revenue/ EPS)
+7.24%
/+9.67%
IQVIA Holdings Inc. earnings per share and revenue
On Jul 28, 2026, IQV reported earnings of 3.15 USD per share (EPS) for Q2 26, beating the estimate of 3.06 USD, resulting in a 2.92% surprise. Revenue reached 4.37 billion, compared to an expected 4.34 billion, with a 0.54% difference. The market reacted with a +13.94% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 17 analysts forecast an EPS of 3.29 USD, with revenue projected to reach 4.40 billion USD, implying an increase of 4.44% EPS, and increase of 0.66% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Idexx Laboratories Inc
Report Date
Aug 04, 2026 For Q2 26
Estimate
$4.02
Actual
$4.26
Surprise
+6.09%
Waters Corp
Report Date
Aug 04, 2026 For Q2 26
Estimate
$3.03
Actual
$3.05
Surprise
+0.44%
TransMedics Group, Inc. Common Stock
Report Date
Aug 04, 2026 For Q2 26
Estimate
$0.48
Actual
$0.44
Surprise
-8.54%
Veracyte, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.24
Actual
$0.31
Surprise
+28.15%
Alphatec Holdings, Inc.
Report Date
Aug 04, 2026 For Q2 26
Estimate
$0.07
Actual
$0.07
Surprise
-0.43%
PROCEPT BioRobotics Corporation Common Stock
Report Date
Aug 04, 2026 For Q2 26
Estimate
-$0.46
Actual
-$0.47
Surprise
-0.84%
iRadimed Corporation
Report Date
Jul 31, 2026 For Q2 26
Estimate
$0.42
Actual
$0.46
Surprise
+7.38%
SI-BONE, Inc. Common Stock
Report Date
Aug 03, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.09
Surprise
+41.02%
OrthoPediatrics Corp. Common Stock
Report Date
Aug 04, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.26
Surprise
+15.72%
ClearPoint Neuro, Inc. Common Stock
Report Date
Aug 03, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.38
Surprise
-29.96%
FAQ
What were IQVIA Holdings Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, IQVIA Holdings Inc. reported EPS of $3.15, beating estimates by 2.92%, and revenue of $4.37B, 0.54% above expectations.
How did the market react to IQVIA Holdings Inc.'s Q2 2026 earnings?
The stock price moved up 13.94%, changed from $213.22 before the earnings release to $242.94 the day after.
When is IQVIA Holdings Inc. expected to report next?
The next earning report is scheduled for Oct 26, 2026.
What are the forecasts for IQVIA Holdings Inc.'s next earnings report?
Based on 17
analysts, IQVIA Holdings Inc. is expected to report EPS of $3.29 and revenue of $4.40B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement